The most common oncogenic driver mutation in lung cancer is epidermal growth factor receptor (EGFR) mutation, which characterizes approximately 40–55% of all NSCLC in Asian patients (Shi et al. 2014). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.